ORLANDO, Florida – (COMMERCIAL THREAD) – MITER announced Compass ™, a premier open source application for collecting minimum common oncology data elements, or mCODE ™, from electronic health records (EHRs), today at HIMSS19 Global Conference and Exhibition. Only three percent of adult cancer patients participate in clinical trials, which limits access to high-quality data on several types of cancer. mCODE is a new data standard under development that will facilitate the discovery of high quality data for multiple cancer use cases.
“Advances in cancer care and research rely on high quality, shareable data,” commented Dr Brian Anderson, head of clinic at MITER. “While mCODE is a standardized set of cancer data points in health records, Compass is a tool that extracts that data, organizes and informs physicians, patients and researchers. ”
Compass is a SMART (Substitutable Medical Applications and Reusable Technologies) application on FHIR (Healthcare Rapid Interoperability Resources) that extracts mCODE data elements from electronic health records to provide reports to providers and patients – enabling a better diagnosis, better care planning and shared decision making at the point of care.
Most almost 15 million people living with cancer in the United States have EHRs of some sort. However, many of the 1,500 EHR systems used are incompatible, limiting the valuable information cancer researchers could derive from these records.
The development of the mCODE data standard is led by the American Society for Clinical Oncology (ASCO), in collaboration with MITER and other stakeholders, to improve the interoperability of data and records in oncology care and research. An early version of the mCODE building blocks, reflecting the initial use cases, is open for comment and almost ready for release.
MITER to collaborate with Brigham and Women’s Hospital on mCODE
MITER and Brigham and Women’s Hospital also announced their intention to strategically plan an mCODE implementation pilot at Boston Hospital. The teams are exploring the potential of a research study to demonstrate the benefits of entering, capturing and displaying structured data for frontline clinicians.
“We are proud to collaborate with Brigham and Women’s to research potential opportunities to pilot the use of mCODE in a clinical research setting,” said Andre Quina, principal investigator at MITER. “Providers and patients are already discussing the most important information about care, and we want to make sure, through trials, that we capture the right data, at the right time, to conduct the best possible research and treatment for the disease. Cancer. ”
Compass overview and demonstrations during HIMSS19
On Tuesday, February 12, Dr Brian Anderson and Andre Quina will provide an overview of Compass when they co-present mCODE: a cancer model for a learning health system at HIMSS19. Compass demonstrations will continue until Thursday, February 14e
at the MITER booth, in the federal health IT solutions pavilion, stand 8267-08.
Discover mCODE and Compass:
About MITER Corporation
MITER’s mission-driven teams are dedicated to solving problems for a safer world. Through our federally funded R&D centers and public-private partnerships, we work across government to meet the challenges of our country’s security, stability and well-being.
mCODE is a registered trademark of the American Society of Clinical Oncology. Used with permission.